More than 125 medtech customers use ³ΤΉΟ±¬ΑΟ applications for seamless execution across product development
PLEASANTON, CA β Oct. 2, 2024 β ³ΤΉΟ±¬ΑΟ Systems (NYSE: VEEV) today announced that 18 of the top 20 medtech companies leverage ³ΤΉΟ±¬ΑΟ Development Cloud and ³ΤΉΟ±¬ΑΟ Commercial Cloud applications to streamline processes across the total medtech product lifecycle. ³ΤΉΟ±¬ΑΟ MedTech enables more than 125 customers with deep industry expertise and technology from ideation to commercialization. With an increasing need to keep up with market changes for faster time to market, medtech companies are moving to connected applications on a single cloud platform to execute key processes more efficiently.
βWith dozens of studies across hundreds of global sites, simplifying clinical operations with unified document management and streamlined workflows is a top priority,β said Matt Christensen, senior vice president at Smith+Nephew. βUsing ³ΤΉΟ±¬ΑΟ MedTechβs unified clinical solution drives transparency, ensures integrity of study files, and speeds trial timelines.β
³ΤΉΟ±¬ΑΟ MedTech enables end-to-end product lifecycle management with ³ΤΉΟ±¬ΑΟ Clinical, ³ΤΉΟ±¬ΑΟ RIM, ³ΤΉΟ±¬ΑΟ Quality, and ³ΤΉΟ±¬ΑΟ Commercial. Using advanced applications built with medtech industry best practices, customers can access real-time insights to make data-driven decisions, automate processes, and maintain inspection readiness. This reduces manual work and improves cross-team collaboration while driving growth, cost efficiency, and compliance.
βThis momentum shows that the global medtech industry has made great strides in modernizing systems, establishing a foundation across the product lifecycle to leverage into the future,β said Seth Goldenberg, vice president, ³ΤΉΟ±¬ΑΟ MedTech. βWith the top medtech leaders standardizing on ³ΤΉΟ±¬ΑΟ applications, we will continue to learn and advance the industry toward more streamlined processes to deliver innovative new devices and diagnostics to patients in need.β
More than 200 industry professionals will network, share best practices, and hear valuable insights from medtech leaders, including Bio-Rad Laboratories, Philips, and ZEISS Medical Technology, at ³ΤΉΟ±¬ΑΟ MedTech EU Summit. Medtech industry professionals can register for the Nov. 5 – 7 event in Amsterdam.
³ΤΉΟ±¬ΑΟ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³ΤΉΟ±¬ΑΟ serves more than 1,000 customers, ranging from the worldβs largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³ΤΉΟ±¬ΑΟ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
This release contains forward-looking statements regarding ³ΤΉΟ±¬ΑΟβs products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2024, which you can find (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at .
###
Contact:
Deivis Mercado
³ΤΉΟ±¬ΑΟ Systems
925-226-8821
deivis.mercado@veeva.com